Patients Dispensed Medications with Actionable Pharmacogenomic Biomarkers: Rates and Characteristics

PURPOSE. Pharmacogenomic biomarkers are increasingly listed on medication labels and authoritative guidelines but pharmacogenomic-guided prescribing is not yet common. Our objective was to assess the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dianbo, Olson, Karen L., Manzi, Shannon F., Mandl, Kenneth D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067543/
https://www.ncbi.nlm.nih.gov/pubmed/33420348
http://dx.doi.org/10.1038/s41436-020-01044-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067543/
https://www.ncbi.nlm.nih.gov/pubmed/33420348
http://dx.doi.org/10.1038/s41436-020-01044-2

Ejemplares similares